We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current DAWN market cap is 1.41B. The company's latest EPS is USD -1.8733 and P/E is -7.32.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 8.19M | 93.76M |
| Operating Income | -51.44M | -59.52M | -66.77M | -114.81M | 29.64M |
| Net Income | -46.15M | -54.51M | -62.41M | -4.41M | 37.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.91M | -13.78M | -72.74M | -146.91M | -206.06M |
| Net Income | -12.63M | -40.51M | -170.64M | -142.18M | -188.92M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 414.18M | 376.05M | 326.65M | 400.44M | 600.81M |
| Total Liabilities | 24.55M | 29.51M | 29.84M | 93.71M | 45.34M |
| Total Equity | 389.63M | 346.54M | 296.81M | 306.73M | 555.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 27.34M | 45.66M | 289.82M | 349.06M | 376.05M |
| Total Liabilities | 2.02M | 2.2M | 8.67M | 17.02M | 29.51M |
| Total Equity | -10.67M | -54.21M | 281.15M | 332.04M | 346.54M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -105.48M | -146.85M | -49.73M | -98.86M | -48.11M |
| Investing | 98M | 128.38M | 89.29M | 106.35M | 38.65M |
| Financing | 163.4M | 164M | 48k | 1.35M | 201.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.52M | -13.49M | -48.54M | -109.87M | -146.85M |
| Investing | N/A | -92k | -8M | -255.07M | 128.38M |
| Financing | 30.91M | 29.98M | 297.12M | 165.9M | 164M |
| Market Cap | 1.41B |
| Price to Earnings Ratio | -7.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.99 |
| Price to Book Ratio | 3.99 |
| Dividend Yield | - |
| Shares Outstanding | 100.85M |
| Average Volume (1 week) | 1.16M |
| Average Volume (1 Month) | 1.34M |
| 52 Week Change | 15.35% |
| 52 Week High | 18.0699 |
| 52 Week Low | 11.30 |
| Spread (Intraday) | 0.43 (3.07%) |
| Company Name | Day One Biopharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dayonebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
